Literature DB >> 18582386

Cystitis due to the use of ketamine as a recreational drug: a case report.

Britt Colebunders1, Peter Van Erps.   

Abstract

INTRODUCTION: Ketamine is a derivative of phencyclidine and is a dissociative anaesthetic. Its use as a recreational drug is on the increase among young adults attending clubs and parties. CASE
PRESENTATION: We describe the case of a 20-year-old man who presented with a 7-month history of urinary frequency, nocturia, urgency, suprapubic discomfort during micturition and episodes of severe haematuria shortly after commencing weekly recreational ketamine use. Complementary examinations were negative except for a thickened bladder wall on ultrasound examination and mild inflammatory changes on cystoscopy. So far only nine cases of ketamine-associated ulcerative cystitis have been described.
CONCLUSION: We expect that in the future an increasing number of cases of cystitis caused by ketamine use will be seen in young adults.

Entities:  

Year:  2008        PMID: 18582386      PMCID: PMC2443371          DOI: 10.1186/1752-1947-2-219

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


Introduction

Ketamine is a derivative of phencyclidine, a popular street drug which is known as 'PCP' or 'angel dust'. Ketamine is less potent and shorter acting compared with phencyclidine and is used as a dissociative anaesthetic in humans [1]. Ketamine, known as 'Special K', is becoming more widely used among young adults attending clubs and parties, including raves [2]. It is labelled a 'club drug' by the National Institute on Drug Abuse (NIDA) of the United States. The effects of ketamine include profound changes in consciousness and psychotomimetic symptoms, such as out-of-body experiences [3]. It can also induce a state of virtual helplessness and a pronounced lack of coordination [4]. Negative effects include increased heart and respiratory rates, nausea and vomiting, convulsions, temporary paralysis and hallucinations [2]. So far only one report has described the effect of ketamine on the urinary system: nine patients were found to have developed a ketamine-associated ulcerative cystitis [5]. We report an additional case.

Case presentation

We describe the case of a 20-year-old man who presented with a 7-month history of urinary frequency, nocturia, urgency, suprapubic discomfort during micturition and episodes of severe haematuria shortly after commencing weekly recreational ketamine use. The patient occasionally works as a disk jockey at 'hardstyle' and 'jump' parties. His past medical history was significant for nose polyps and asthma, for which he was treated with montelukast (Singulair®) and fluticasone propionate in combination with salmeterol (Seretide®). He had never travelled outside of Europe. After 2 months of symptoms he had been treated with antibiotics for 5 days and anticholinergics for several weeks without any improvement. Routine urine analysis and urine cytology were negative and a urine culture was sterile. An ultrasound examination revealed a thickened bladder wall and a small bladder capacity but normal kidneys. Cystoscopy showed mild inflammatory changes, although there was no visual blood in the urine. Bladder biopsies were negative; however, they were not taken during an episode of active cystitis. We advised the patient to stop ketamine use.

Discussion

Ketamine-associated cystitis appears to be a new clinical entity. So far only nine cases have been described, all of which reported daily ketamine users who presented with severe dysuria, frequency, urgency and severe haematuria [5] (Table 1). Urine cultures were sterile in all patients. Computed tomography revealed marked thickening of the bladder wall, a small bladder capacity and perivesicular stranding, consistent with severe inflammation. At cystoscopy, the bladder walls of eight patients showed multiple erythematous patches. In one patient mild squamous metaplasia and reddened flat ulcerated patches were noted on cystoscopy. Biopsies in four patients revealed epithelial denudation and inflammation with a mild eosinophilic infiltrate. All patients benefited from cessation of ketamine use. In one case the addition of pentosane polysulphate appeared to provide some symptomatic relief.
Table 1

Characteristics of 10 patients with ketamine-associated cystitis reported in the literature.

Our patientPatient 1Patient 2Patient 3Patients 4–9
Age20 years28 years25 years17 yearsUnknown
SexManManWomanManUnknown
Ketamine useWeeklyDailyDailyDailyDaily
Duration of symptoms7 months6 months2 yearsSeveral monthsUnknown
Urine culturesSterileSterileSterileSterileSterile
Bladder wallThickenedThickenedThickenedThickenedThickened
CystoscopyMild inflammationErythematous patchesMild squamous metaplasia, ulcerated patchesErythematous patchesErythematous patches
BiopsyNegativeEpithelial denudation, inflammation, eosinophilic infiltrateUnknownUnknownIn three patients, similar to patient 1
Antibiotic therapyUnsuccessfulUnsuccessfulUnknownUnknownUnknown
Benefited from cessation of ketamineUnknownYesYesYesYes
Characteristics of 10 patients with ketamine-associated cystitis reported in the literature. In our case cystoscopy showed only mild signs of inflammation and biopsies were negative. However, our patient used ketamine only on a weekly basis, whereas the patients described in the literature were daily users. This could explain the difference between our patient's cystoscopy and biopsy findings with those of the nine cases reported in the literature. Moreover, in our patient the biopsies were not taken during an episode of active cystitis. We suspect, however, that ketamine was the cause of the patient's complaints, as the timing of the onset of symptoms correlated strongly with the commencement of ketamine use. In addition, the evidence shows our case to be consistent in many ways with the nine other cases described in the literature (Table 1). The mechanism by which ketamine induces cystitis is not clear. Ketamine and its metabolites norketamine and hydroxynorketamine can be measured in high quantities in the urine of patients using ketamine [6]. It is possible that ketamine and its active metabolites cause significant bladder irritation.

Conclusion

As ketamine is being used increasingly as a recreational drug we expect ketamine-associated cystitis to become more prevalent in young adults. Health care workers should be aware of the problem and patients should be informed about the possible side effects of ketamine. The long-term sequelae of ketamine on the bladder remain unknown.

Competing interests

The authors declare that they have no competing interests.

Consent

Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Authors' contributions

BC reviewed the literature, and conceived of and drafted the manuscript, PVE is the department chair, who provided general support. Both authors revised and approved the manuscript.
  5 in total

1.  Urine concentrations of ketamine and norketamine following illegal consumption.

Authors:  K A Moore; J Sklerov; B Levine; A J Jacobs
Journal:  J Anal Toxicol       Date:  2001-10       Impact factor: 3.367

2.  Non-medical use of ketamine.

Authors:  K L Jansen
Journal:  BMJ       Date:  1993-03-06

3.  Patterns of use and harms associated with non-medical ketamine use.

Authors:  Paul Dillon; Jan Copeland; Karl Jansen
Journal:  Drug Alcohol Depend       Date:  2003-01-24       Impact factor: 4.492

4.  Ketamine-associated ulcerative cystitis: a new clinical entity.

Authors:  Rohan Shahani; Cathy Streutker; Brendan Dickson; Robert J Stewart
Journal:  Urology       Date:  2007-05       Impact factor: 2.649

Review 5.  Ketamine: a new look to an old drug.

Authors:  G Ivani; C Vercellino; F Tonetti
Journal:  Minerva Anestesiol       Date:  2003-05       Impact factor: 3.051

  5 in total
  12 in total

1.  Intact urothelial barrier function in a mouse model of ketamine-induced voiding dysfunction.

Authors:  Retnagowri Rajandram; Teng Aik Ong; Azad H A Razack; Bryce MacIver; Mark Zeidel; Weiqun Yu
Journal:  Am J Physiol Renal Physiol       Date:  2016-02-24

2.  Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine.

Authors:  David M Wood; Susannah Davies; Malgorzata Puchnarewicz; Atholl Johnston; Paul I Dargan
Journal:  Eur J Clin Pharmacol       Date:  2011-12-29       Impact factor: 2.953

3.  Ketamine-associated ulcerative cystitis: a case report and literature review.

Authors:  Christopher Chee Kong Ho; Hafez Pezhman; Singam Praveen; Eng Hong Goh; Boon Cheok Lee; Md Zainuddin Zulkifli; Mohamed Rose Isa
Journal:  Malays J Med Sci       Date:  2010-04

Review 4.  Street ketamine-associated bladder dysfunction: an emerging health problem.

Authors:  Py Lee; Ta Ong; Cb Chua; Ccm Lei; Gc Teh
Journal:  Malays Fam Physician       Date:  2009-04-30

5.  A pilot study of urine cytokines in ketamine-associated lower urinary tract symptoms.

Authors:  Rachel Y K Cheung; Jacqueline H S Lee; Symphorosa S C Chan; Dawn W T Liu; K W Choy
Journal:  Int Urogynecol J       Date:  2014-06-28       Impact factor: 2.894

6.  Clinical significance of interleukin‑6 and inducible nitric oxide synthase in ketamine‑induced cystitis.

Authors:  Chi-Jung Huang; Fa-Kung Lee; Shao-Kuan Chen; Chih-Cheng Chien; Sheng-Tang Wu; Yen-Chieh Wang
Journal:  Int J Mol Med       Date:  2017-11-17       Impact factor: 4.101

7.  Effective treatment of ketamine-associated cystitis with botulinum toxin type a injection combined with bladder hydrodistention.

Authors:  Jianfeng Zeng; Haibiao Lai; Dongxiang Zheng; Liang Zhong; Zhifeng Huang; Shanyun Wang; Weiwei Zou; Lianbo Wei
Journal:  J Int Med Res       Date:  2017-03-08       Impact factor: 1.671

8.  Autophagy Alters Bladder Angiogenesis and Improves Bladder Hyperactivity in the Pathogenesis of Ketamine-Induced Cystitis in a Rat Model.

Authors:  Jian-He Lu; Yi-Hsuan Wu; Tai-Jui Juan; Hung-Yu Lin; Rong-Jyh Lin; Kuang-Shun Chueh; Yi-Chen Lee; Chao-Yuan Chang; Yung-Shun Juan
Journal:  Biology (Basel)       Date:  2021-05-30

9.  Mast cells infiltration and decreased E-cadherin expression in ketamine-induced cystitis.

Authors:  Mengqiang Li; Kang Yang; Xiujian Wang; Xiaodong Xu; Ling Zhu; Huili Wang
Journal:  Toxicol Rep       Date:  2014-12-08

10.  Recreational ketamine-related deaths notified to the National Programme on Substance Abuse Deaths, England, 1997-2019.

Authors:  John Martin Corkery; Wan-Chu Hung; Hugh Claridge; Christine Goodair; Caroline S Copeland; Fabrizio Schifano
Journal:  J Psychopharmacol       Date:  2021-06-05       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.